Searched for
ELI LILLY DIABETES DRUG
Worried about blood-sugar spikes after feasting? A tablespoon of a cheap kitchen ingredient can reduce blood sugar levels after meals, says ‘Glucose Goddess’Although it can taste rather sour, vinegar can bring a rather sweet deal for diabetic people who are foodies. In a viral video, health and ...- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
- Kareena Kapoor Khan’s dietician busts myths about ghee, rice and bananas, warns boycotting one of these foods can increase hair fallMost Indians have a weakness for rice, ghee and bananas. In the summer, having a plate of piping hot ghee-soaked rice or snacking on a bana...
- Woman with type 1 diabetes shares the 15-minute habit that helps lower her blood sugarFor a woman managing type one diabetes, brisk walking becomes a key strategy for regulating high blood sugar. During physical activity, the...
- Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targetsElara has initiated coverage on four pharmaceutical stocks, assigning Buy, Accumulate and Reduce ratings. Alkem Laboratories emerged as its...
- Convening India's brightest minds: The Bharat Life Sciences Award’s Innovation Summit to spotlight life sciencesIndia sets its sights on becoming a frontrunner in innovation within the life sciences arena. The Bharat Life Sciences Award 2026 aims to h...
- Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...
- White House to announce new drug pricing deals with biotechs: ReportThe Trump administration is expected to announce voluntary drug-pricing agreements with midsize biotech companies, requiring discounts for ...
- USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observationsAurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducte...
- Eli Lilly launches oral weight-loss pill Foundayo in UKEli Lilly has launched its oral weight management pill Foundayo in the United Kingdom. This new treatment, chemically known as orforglipron...
- GLP-1 drugs create new market for collagen, protein and beauty products in IndiaThe rising use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with companies developin...
- Delhi High Court rules in favour of Dr Reddy's Labs in trademark row with RazentaThe Delhi High Court ordered the removal of Razenta Pharmaceuticals' Daplogin trademark. This decision came as the mark was deemed deceptiv...
- In 2019, research began with users of anti-diabetes treatment medicines, now study shows side effect could be hair lossDiabetes treatment: The researchers said while the study was a rigorous one, based on high quality data from a large representative cohort,...
- Mankind Pharma inks in-licensing pact with China's Chongqing Chenan BiopharmaceuticalMankind Pharma has secured an exclusive agreement with Chongqing Chenan Biopharmaceutical. This partnership focuses on commercialising two ...
- Nestle looks to develop new products to serve users of weight-loss drugsNestle is developing specialized products for GLP-1 weight-loss drug users. Artificial intelligence aids in analyzing research and identify...
- In 2020, Alzheimer’s diagnose process received major breakthrough approval, six years later 7 million patient in U.S. get another big announcement for progressive brain disease treatmentMore than 7 million people in the United States have Alzheimer's, and the number of people aged 65 or older with the disease could exceed ...
- UK first in Europe to approve Eli Lilly oral weight loss drugBritain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...
- Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetesBritain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...
- Novo CEO says setbacks demand faster research, acquisitions as investors fret over pipelineNovo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...
- Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug adsNovo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers...
Load More
